Agile_Logo-color on white.jpg
Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary
October 04, 2021 08:02 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that the California Medicaid Program, Medi-Cal, has placed...
Agile_Logo-color on white.jpg
Agile Therapeutics Partners with Carli Lloyd, U.S. Women’s Soccer Star and Four-Time Olympian, to Bring Awareness to Women’s Health Topics
September 28, 2021 08:01 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today a partnership with U.S. Women’s Soccer legend, Carli Lloyd....
Agile_Logo-color on white.jpg
Agile Therapeutics Partners with Telehealth Service, Pandia Health, to Increase Women’s Access to Twirla® (levonorgestrel and ethinyl estradiol) transdermal system
August 20, 2021 07:30 ET | Agile Therapeutics, Inc.
Pandia Health is a doctor founded and led telehealth company, offering online prescriptions and free delivery designed to make it easier for women to access birth control options that meet their...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Presentation of Safety and Efficacy Data of Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal System in Women of Differing BMI Categories at ACOG Annual Meeting
April 30, 2021 11:01 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial...
22157.jpg
United States Transdermal Patch Market Report 2021-2026: Dosage, Price & Clinical Trials Insights - Technology Innovation and Increasing Acceptability Toward Patch Drug Delivery Methodology
March 30, 2021 06:28 ET | Research and Markets
Dublin, March 30, 2021 (GLOBE NEWSWIRE) -- The "US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. US...
Agile_Logo-color on white.jpg
Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results; Expands Loan Facility With Perceptive Advisors
March 01, 2021 16:05 ET | Agile Therapeutics, Inc.
Perceptive Advisors Increases Credit Facility to $45 million, with $25 million potentially available Achieved Gross Revenue Target In Fourth Quarter 2020, Reflecting Initial Stocking of Twirla®...
Agile_Logo-color on white.jpg
Agile Therapeutics Inc. Hosts First Analyst Day Focused on Previewing its Corporate Vision and Commercial Strategy
October 10, 2017 18:38 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s healthcare company, today hosted the Company’s first analyst day in New York City to showcase its...
Agile_Logo-color on white.jpg
Agile Therapeutics to Host First Analyst Day on October 10, 2017
October 02, 2017 07:30 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that the Company will host its first Analyst Day on Tuesday,...
Agile_Logo-color on white.jpg
Agile Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
September 14, 2017 07:45 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company, announced today that Al Altomari, Chairman and CEO,...
Agile_Logo-color on white.jpg
Agile Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
August 22, 2017 07:30 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 22, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company, announced today that Al Altomari, Chairman and CEO will...